U.S., May 8 -- ClinicalTrials.gov registry received information related to the study (NCT07573579) titled 'Dynamic Voltage Mapping to Personalise the Ventricular Tachycardia Substrate' on April 22.
Brief Summary: Ventricular tachycardia (VT) is a life-threatening heart rhythm disorder and one of the commonest causes of heart-related sudden death. It often affects people who have had a heart attack or other structural heart damage. VT occurs when abnormal electrical circuits develop within and around scar tissue in the heart.
People at risk are usually offered an implantable cardiac defibrillator (ICD), a device that can detect VT and deliver a lifesaving shock. While effective, these shocks can be sudden, painful and distressing. Medicati...